# A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection

> **NCT04858620** · PHASE3 · WITHDRAWN · sponsor: **Larkin Community Hospital**

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Xlear Nasal Spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04858620
- **Lead sponsor:** Larkin Community Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-08-30
- **Primary completion:** 2021-08-30
- **Final completion:** 2021-08-30
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study Period Ended / Not Completed
- **Last updated:** 2023-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04858620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04858620, "A Study to Evaluate the Efficacy of Xlear vs. Placebo for Acute COVID-19 Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04858620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*